Sartorius sets up Life Science Factory for startup entrepreneurs
Sartorius CEO Joachim Kreuzburg (center) and the two Life Science Factory Managing Directors Marco Janezic (left) and Sven Wagner (right) (copyright: Sartorius; photographer: Swen Pförtner)
Life Science Factory gGmbH offers labs, co-working spaces and consulting services for life science entrepreneurs.
With its newly founded, independent Life Science Factory, Sartorius intends to promote startups and attract entrepreneurs from the life science sector.
Life Science Factory offers space and support to prospective scientific entrepreneurs and young companies willing to take their first steps beyond the comfort zone of academic institutions. Based on an exemplary business model already established in the US as a launch pad for life science startups, the Life Science Factory strategy provides for the interaction of lab areas, coworking rooms and network offerings, such as mentoring and company financing. The firm’s professional operating concept ensures efficient facility management and administrative support, high-quality laboratory equipment and qualified lab staff.
“In this combination, such an approach is new in Germany and other European countries,” comments Sartorius Executive Board Chairman and CEO Joachim Kreuzburg. “Life science startups primarily lack suitable lab facilities and a powerful network, apart from access to startup and growth capital. Flexible and open-design spaces for labs, offices and events are a good breeding ground for trying out new things and sharing contacts and experiences with like-minded peers and veteran founders.“ He says that Life Science Factory is intended to propel Göttingen beyond its reputation focusing on scientific expertise, establishing the city as a genuine hotspot for life science startups. The managing directors of Life Science Factory gGmbH, a non-profit, are entrepreneur and founder Marco Janezic and Sven Wagner, who heads the Business Development unit at Sartorius and had previously worked at two life science startups.
Life Science Factory will work closely with local partners, such as Göttingen’s universities, MaxPlanck institutes and the Southern Lower Saxony Innovation Campus, SNIC, and, beyond these, with its wider network. For example, the non-profit will be the venue for startup activities of the Fraunhofer-Gesellschaft, Europe’s largest application-oriented research organization, such as Fraunhofer Life Science Days, or for the initiative of the Young Entrepreneurs in Science of the Falling Walls Foundation. “Göttingen has the potential and the opportunity to achieve a much stronger position in this extremely dynamic and socially important field than has been the case so far,” says Kreuzburg.
The non-profit will be ready to start off in early 2019: Office space in the inner city of Göttingen will be available on more than 500 m2 for co-working, experiments and events, and can be rented by entrepreneurs for working and prototype building. The offices will also offer the latest equipment, such as 3-D printers and laser cutters. In addition, lectures to be held by patent attorneys or successful startup founders, for instance, are scheduled as are further events addressing startup issues. Any earnings generated by Life Science Factory will be reinvested in the promotion of knowledge transfer and of young scientists and researchers.
In 2021, Life Science Factory plans to move to the new Sartorius Quarter. Providing a total area of more than 3,000 square meters, the new facility for Life Science Factory will be one of the first buildings to open in the new city quarter at the previous Sartorius site. “Our former company headquarters was always a place of taking entrepreneurial initiative and of turning science into practical industrial solutions, especially in life sciences. For this reason, the Sartorius Quarter is also designed to continue as a place for ideas and innovations in the future as well. Through this Life Science Factory, our company is upholding its long-term commitment to this location and thus to also close a gap in Göttingen,” says Kreuzburg. At the end of 2017, Sartorius relocated its headquarters after operating for some 120 years at its traditional site in the inner city of Göttingen to Sartorius Campus in the Göttingen-Grone industrial zone.
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.